Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 71382

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 19, 2015
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Hospira Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Magnesium Sulfate Injection, USP, 50%, 20mL, Single dose Fliptop Vial, For IV or IM use, Rx only, Manufactured by Hospira, Inc. 4285 Wesleyan Blvd Rocky Mount, NC 27804 for Hospira, Inc. 275 N Field Drive, Lake Forest, IL 60045. NDC 0409-2168-02

D-1232-2015
Recall number
D-1232-2015
Initiated
May 19, 2015
Classification
Class III
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
106,900 vials

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Failed pH Specifications: 12 month stability testing

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed pH Specifications: 12 month stability testing

Code information

Lot #: 39-569-DK, Exp 3/1/2016

Distribution pattern

U.S. Nationwide, Kuwait, Bahrain and Israel.